4//SEC Filing
NovaBay Pharmaceuticals, Inc. 4
Accession 0001437749-16-027192
$NBYCIK 0001389545operating
Filed
Mar 8, 7:00 PM ET
Accepted
Mar 9, 8:06 PM ET
Size
5.1 KB
Accession
0001437749-16-027192
Insider Transaction Report
Form 4
SIECZKAREK MARK M
Director
Transactions
- Award
Restricted Stock Units
2016-03-09+58,692→ 58,692 total→ Common Stock (58,692 underlying)
Footnotes (2)
- [F1]Each RSU represents the right to receive, at settlement, one share of common stock. This transaction represents the settlement of RSUs in shares of common stock on their scheduled vesting date.
- [F2]Granted pursuant to the 2007 Omnibus Incentive Plan as compensation for the period between November 19, 2015 and March 31, 2016. Vests ratably at the end of every month subject to continued employment.
Documents
Issuer
NovaBay Pharmaceuticals, Inc.
CIK 0001389545
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001389545
Filing Metadata
- Form type
- 4
- Filed
- Mar 8, 7:00 PM ET
- Accepted
- Mar 9, 8:06 PM ET
- Size
- 5.1 KB